Login to Your Account



Other News To Note


Wednesday, December 12, 2012
• Cardiome Pharma Corp., of Vancouver, British Columbia, reached an agreement with Merck & Co. Inc., of Whitehouse Station, N.J., to settle its debt obligations stemming from the companies' collaboration and license agreement for heart drug vernakalant, signed in April 2009 and subsequently terminated.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription